Paul-Ehrlich-Institut

Go to:

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Bulletin on Drug Safety – Current Issue 4/2024 Published

The Bulletin on Drug Safety is a cooperation between the Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) and the Paul-Ehrlich-Institut (PEI). The quarterly publication provides information from both federal institutes on current aspects of the assessment of drugs. It focuses on pharmacovigilance – the continuous monitoring and evaluation of drug safety before and after marketing authorisation. The Bulletin includes articles on individual drugs as well as background information for understanding pharmacovigilance and research in this area.

The publication is available in German only.

Topics in the Current Issue

  • Editorial: 30 Years of BfArM
  • Comparison of adverse menstrual events before (or without) and after COVID-19 vaccination
  • Drug therapy for girls and women of childbearing age with multiple sclerosis
  • Reports from BfArM and PEI
  • PRAC recommendations within EU referral procedures – October to December 2024
  • Revised product information wording – Extracts from the PRAC recommendations on signals
  • References to direct healthcare professional communications (Rote-Hand-Briefe) and safety information

Further Information

Bulletin on Drug Safety, Issue 4/2024 (German only)
www.pei.de/bulletin-safety

Updated: 18.12.2024